Public health officials have hailed Merck for its drug donations as it announced that Colombia has eliminated onchocerciasis (river blindness) within its borders.

Colombia is the first country with the disease in the Americas to reach this goal.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Speaking at the 21st Inter-American Conference in Bogota, Colombia, health officials also praised health education group the Carter Center for its work in helping to eliminate the disease.

It was also announced that Guatemala and Mexico have broken the cycle of transmission of river blindness, and both countries intenf to halt their drug treatment programmes next year.

The countries will then begin the three-year post-treatment monitoring process.

The Carter Center, through its Onchocerciasis Elimination Program for the Americas partnership, assists national ministries of health in Latin America to conduct health education and distribute Merck’s medicine, Mectizan (ivermectin).

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact